🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,400
+850 (3.94%)
At close: Nov 17, 2026

HEM Pharma Revenue

HEM Pharma had revenue of 4.57B KRW in the quarter ending June 30, 2026, with 60.82% growth. This brings the company's total for the last twelve months to 16.14B, up 1.54% year-over-year. In the year 2025, HEM Pharma had annual revenue of 12.98B, down -13.86%. That makes HEM Pharma the 36,535th largest company in the world by revenue and 2,340th in South Korea.

Revenue (ttm)
16.14B
Revenue Growth
+1.54%
P/S Ratio
10.00
Revenue / Employee
273.59M
Employees
59
Market Cap
161.48B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.98B-2.09B-13.86%
Dec 31, 202415.07B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.